Sunshine Biopharma SBFM
NASDAQ SBFM
$2.75 +0.04 (+1.48%)
At close: Nov 9, 2026 · 4:00 PM EST

Sunshine Biopharma (SBFM) Income from Discontinued Operations (2018 - 2019)

Updated

Sunshine Biopharma (SBFM) recorded Income from Discontinued Operations of -$580,125 in Q4 2019, compared with -$9,357 a year earlier.

Analysis

Sunshine Biopharma (SBFM) Income from Discontinued Operations (2018 - 2019) Analysis & Trends

For FY2019, Sunshine Biopharma reported Income from Discontinued Operations of -$582,237.

  • Across earlier years, Income from Discontinued Operations came in at -$18,204 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Sunshine Biopharma 187,731.50 -38.90 Mn 2.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -580,125.00
Sep 30, 2019 -2,112.00
Jun 30, 2019 -2,112.00
Dec 31, 2018 -9,357.00
Sep 30, 2018 5,278.00
Jun 30, 2018 5,413.00
API Access

Sunshine Biopharma Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=SBFM&period=max&api_key=YOUR_API_KEY